VEXAS Clinical Trials in Lille
2 recruitingLille, France
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
VEXAS SyndromeVEXAS
Swedish Orphan Biovitrum78 enrolled39 locationsNCT06782373
Recruiting
Phase 2
Momelotinib in VEXAS Syndrome
VEXAS SyndomeMyelo Dysplastic Syndrome
Groupe Francophone des Myelodysplasies57 enrolled11 locationsNCT07098936